WatchlistCoins

Immunotherapies, such as CAR-T cell therapy and bispecific antibody therapy, have been introduced to treat relapsed or refractor

MEDIEUS
MEDIEUS
Twitter
03 Sep 2023, 12:21
Immunotherapies, such as CAR-T cell therapy and bispecific antibody therapy, have been introduced to treat relapsed or refractory multiple myeloma. #Korea #healthcare #patient #doctor #teglistamab #foodanddrugsafety 👉https://t.co/ft5wc1kAbD🇰🇷🇰🇷🇰🇷🏥🏥🏥